Melatonin and light therapy for idiopathic hypersomnia
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether taking melatonin at night and using a bright light therapy device in the morning can improve excessive daytime sleepiness in people with idiopathic hypersomnia. It is a double-blind study, meaning neither you nor the doctors will know if you are getting the real treatment or a placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old.
- You have been diagnosed with idiopathic hypersomnia (a sleep disorder causing excessive daytime sleepiness and long sleep time) by a specialist.
- Your sleep time is 11 hours or more per day, confirmed by a sleep test in the last year.
- You are not taking certain medications that affect sleep or alertness, and you are willing to stop them for at least a month before the trial.
- You have no major eye disease, serious mental health condition, or substance dependence.
- You are available to follow a strict schedule of taking melatonin at night and using a light therapy device in the morning for 10 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medication called TAK-360 for people with idiopathic hypersomnia (IH), a sleep disorder that causes excessive daytime sleepiness. The goal is to see if the drug can help reduce sleepiness and improve daily function.
This trial tests whether low-dose sodium oxybate can improve symptoms in adults with idiopathic hypersomnia, a condition that causes excessive sleepiness. You’d likely be asked to pause this standard treatment briefly while baseline testing is completed, and you’d use reliable contraception during and after the study drug.
This trial tests a new medication, HBS-301, in people with idiopathic hypersomnia (a condition causing excessive sleepiness without clear cause). It aims to see if the drug improves wakefulness and is safe.
This trial tests a new medicine called ALKS 2680 for people with Idiopathic Hypersomnia (a condition that causes extreme sleepiness without a clear cause). The goal is to see if it is safe and effective at helping you stay awake during the day.
This trial tests a medication, solriamfetol, to see if it helps people with idiopathic hypersomnia stay awake during the day. It may be an option if you have trouble staying awake despite getting enough sleep at night.
This trial studies whether timed light exposure can help people who have trouble falling asleep. It aims to improve insomnia symptoms by testing a light-based approach while carefully measuring sleep patterns.
Hear when a new Idiopathic Hypersomnia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.